ANTIMICROBIAL RESISTANCE

Similar documents
Mechanism of antibiotic resistance

Caitlin DeWilde,

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Microbiology ( Bacteriology) sheet # 7

WHY IS THIS IMPORTANT?

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

An#bio#cs and challenges in the wake of superbugs

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Mechanisms and Pathways of AMR in the environment

Antimicrobial Resistance and Prescribing

Antimicrobials & Resistance

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antimicrobial Cycling. Donald E Low University of Toronto

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antibiotic resistance: how did we get here and what can we do? Peter Lambert LHS

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Antimicrobial Resistance

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Overview of antibiotic combination issues.

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Global Alliance for Infections in Surgery. Better understanding of the mechanisms of antibiotic resistance

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Antibiotics & Resistance

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

ANTIBIOTIC Resistance A GLOBAL THREAT Robero JJ

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

Other Beta - lactam Antibiotics

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Antimicrobial agents. are chemicals active against microorganisms

Antimicrobial Therapy

Lecture 6: Fungi, antibiotics and bacterial infections. Outline Eukaryotes and Prokaryotes Viruses Bacteria Antibiotics Antibiotic resistance

Rise of the Superbugs: the end of antibiotics? Peter Lambert Life and Health Sciences Aston University

Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

chapter 15 microbial mechanisms of pathogenicity

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Evolution of antibiotic resistance. October 10, 2005

DSM Sinochem Pharmaceuticals From Gist to Sustainable Antibiotics

Testimony of the Natural Resources Defense Council on Senate Bill 785

The UK 5-year AMR Strategy - a brief overview - Dr Berit Muller-Pebody National Infection Service Public Health England

What is multidrug resistance?

Intrinsic, implied and default resistance

Multi-drug resistant microorganisms

January Walk Your Dog Month National Train Your Dog Month Adopt a Rescued Bird Month. Sunday Monday Tuesday Wednesday Thursday Friday Saturday

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Pet holidays Calendar. I I

Antimicrobial Resistance Strains

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Antibiotic Resistance in Bacteria

β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018

Chapter concepts: What are antibiotics, the different types, and how do they work? Antibiotics

RETROSPECTIVE STUDY OF GRAM NEGATIVE BACILLI ISOLATES AMONG DIFFERENT CLINICAL SAMPLES FROM A DIAGNOSTIC CENTER OF KANPUR

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

EARS Net Report, Quarter

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antimicrobial Resistance Initiative

Mono- versus Bitherapy for Management of HAP/VAP in the ICU

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

How is Ireland performing on antibiotic prescribing?

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Report on the APUA Educational Symposium: "Facing the Next Pandemic of Pan-resistant Gram-negative Bacilli"

Approach to pediatric Antibiotics


The South African AMR strategy. 3 rd Annual Regulatory Workshop Gavin Steel Sector wide Procurement National Department of Health; South Africa

Beta-lactamase Inhibitors May Induce Resistance to Beta-lactam Antibiotics in Bacteria Associated with Clinical Infections Bhoj Singh

Antimicrobial agents

ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS

Antimicrobial Resistance Surveillance from sentinel public hospitals, South Africa, 2013

Nitric Oxide is Bactericidal to the ESKAPE Pathogens: Time for a radical approach

Summary of the latest data on antibiotic resistance in the European Union

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

Mike Apley Kansas State University

COMPARING DNA SEQUENCES TO UNDERSTAND EVOLUTIONARY RELATIONSHIPS WITH BLAST

Origins of Resistance and Resistance Transfer: Food-Producing Animals.

Chemical classifications for biology and medicine

crossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-negative pathogens between

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Chemotherapeutic Agents

What s next in the antibiotic pipeline?

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Transcription:

MECHANISMS OF ANTIMICROBIAL RESISTANCE 2018 Calendar RCSB.ORG A Living Digital Data Resource that Enables Scientific Breakthroughs

January 2018 Bacteria build a tough network of peptidoglycan to support their cell walls. Penicillin V (a beta-lactam antibiotic shown in ball and stick representation) blocks one of the enzymes that builds this peptidoglycan sheath. Penicillin binds to the portion shown in light green. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 31 1 2 3 4 5 6 New Year s Day 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Martin Luther King Jr. Day 21 22 23 24 25 26 27 28 29 30 31 1 2 3 Learn more: rcsb.org pdb101.rcsb.org

February 2018 Bacteria have become remarkably adept at overcoming the effects of even our most powerful antibiotics. Many bacteria now possess enzymes (beta-lactamases) capable of opening up the beta-lactam ring (highlighted in magenta), thereby inactivating the drug. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 28 29 30 31 1 2 3 Groundhog Day 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Valentine s Day Lunar New Year 18 19 20 21 22 23 24 Presidents Day 25 26 27 28 1 2 3 Learn more: rcsb.org pdb101.rcsb.org

March 2018 KPC-2 is another versatile beta-lactamase, with a large and shallow active site that breaks down nearly all known beta-lactam antibiotics. This structure captures the enzyme after it has destroyed a molecule of the broad-spectrum antibiotic cefotaxime. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 26 25 27 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Daylight Saving Time begins (US) Pi Day 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Summer Time begins (Europe) Passover Learn more: rcsb.org pdb101.rcsb.org

April 2018 Bacteria that possess NDM-1 metallo-lactamase enzymes pose a great danger because they can inactivate all approved penicillin-like antibiotics, including our most advanced carbapenems. PDB structures, such as this one with benzylpenicillin, have revealed that NDM-1 uses zinc in its active site to inactivate a wide range of different antibiotics. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 1 2 3 4 5 6 7 Easter 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 Earth Day DNA Day 29 30 1 2 3 4 5 Learn more: rcsb.org pdb101.rcsb.org

May 2018 Aminoglycosides are effective broad-spectrum antibiotics, because they target ribosomes in many types of bacteria. This structure shows how neomycin (yellow) binds to ribosomes and shifts their structure, blocking recycling of ribosomes after they finish building a protein. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Mother s Day Ramadan begins 20 21 22 23 24 25 26 27 28 29 30 31 1 2 Memorial Day Learn more: rcsb.org pdb101.rcsb.org

June 2018 Resistant bacteria block the function of aminoglycoside antibiotics by attaching adenosine nucleotides to them. Structures of the enzymes that perform this reaction may help researchers discover new aminoglycosides that are not susceptible to inactivation. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Eid al-fitr 17 18 19 20 21 22 23 Father s Day 24 25 26 27 28 29 30 Learn more: rcsb.org pdb101.rcsb.org

July 2018 After 40 years of searching, researchers have discovered bedaquiline (shown in yellow), a new drug now approved for the treatment of multidrug-resistant tuberculosis. It binds to the rotor of ATP synthase, blocking the central energy-production machinery of mycobacteria. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 1 2 3 4 5 6 7 Independence Day 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 Learn more: rcsb.org pdb101.rcsb.org

August 2018 Beta-lactamases usually confer resistance by breaking the beta-lactam ring of penicillin-like antibiotics. To overcome resistance, researchers are working to design inhibitors of beta-lactamases that can be given together with established beta-lactam antibiotics. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 Learn more: rcsb.org pdb101.rcsb.org

September 2018 The antibiotic vancomycin (shown on top in ball and stick representation) blocks the process of building bacterial cells walls. Resistant bacteria have responded by developing new enzymes like VanA that build the cell wall in a slightly different way that is not susceptible to the antibiotic. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 25 26 27 28 29 30 1 2 3 4 5 6 7 8 Labor Day 9 10 11 12 13 14 15 Rosh Hashanah 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Yom Kippur 31 Learn more: rcsb.org pdb101.rcsb.org

October 2018 The war of antibiotics and resistance began long before medical science discovered the utility of antibiotics. Researchers reconstructed the vancomycin-resistance enzyme VanA from a 30,000 year old bacterium found in Arctic permafrost, showing it to be very similar to VanA enzymes made by modern bacteria. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 30 1 2 3 4 5 6 7 8 9 10 11 12 13 Columbus Day 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Diwali 28 29 30 31 1 2 3 Summer Time ends (Europe) Halloween Learn more: rcsb.org pdb101.rcsb.org

November 2018 The gene regulator BmrR senses when antibiotics (such as puromycin, in yellow) get into a bacterial cell, directing the synthesis of multidrug efflux pumps to eject them out of the cell. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 28 29 30 31 1 2 3 4 5 6 7 8 9 10 Daylight Saving Time ends (US) 11 12 13 14 15 16 17 Veterans Day 18 19 20 21 22 23 24 Thanksgiving 25 26 27 28 29 30 1 Learn more: rcsb.org pdb101.rcsb.org

December 2018 Bacteria build huge protein pumps that span their cell walls and expel many types of antibiotics. This cryoem structure reveals how the pump works to expel antibiotics from bacterial cells. Sunday Monday Tuesday Wednesday Thursday Friday Saturday 25 26 27 28 29 30 1 2 3 4 5 6 7 8 Hanukkah 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 New Year s Eve Christmas Kwanzaa Learn more: rcsb.org pdb101.rcsb.org

PDB AND ANTIMICROBIAL RESISTANCE (AMR) Antibiotics have saved countless lives, but pathogens are quickly finding ways to survive antibiotic treatment. Antibioticresistant bacteria are predicted to become the leading cause of death worldwide, with an expected death rate of 10 million people, annually, by 2050. 1 They take many approaches: pumping antibiotics out of their cells, altering the molecular machinery that the antibiotics target, and attacking the antibiotics directly. Atomic structures publicly available in the PDB are revealing the details of drug resistance and providing new ways to combat it. 2018 VIDEO CHALLENGE FOR HIGH SCHOOL STUDENTS Every year since 2013, the RCSB PDB invites high school students across the USA to create short videos that tell a molecular story of health and disease. The 2018 video challenge will focus on Antimicrobial Resistance. REFERENCES & IMAGE CREDITS January PDB ID 2ex9 Kishida, H. et al. Crystal structure of penicillin binding protein 4 (dacb) from Escherichia coli, both in the native form and covalently linked to various antibiotics. Biochemistry 45, 783-792 (2006) February PDB ID 5eph Pozzi, C. et al. Crystal structure of the Pseudomonas aeruginosa BEL-1 extended-spectrum beta-lactamase and its complexes with moxalactam and imipenem. Antimicrob Agents Chemother 60, 7189-7199 (2016) March PDB ID 5uj3 Pemberton, O.A. et al. Molecular basis of substrate recognition and product release by the Klebsiella pneumoniae carbapenemase (KPC-2). J Med Chem 60, 3525-3530 (2017) April PDB ID 4eyf King, D.T. et al. New Delhi metallo-beta-lactamase: structural insights into beta-lactam recognition and inhibition. J Am Chem Soc 134, 11362-11365 (2012) Background Image: Klebsiella pneumoniae, the bacterium in which NDM-1 was first identified, on agar plate. Source: Center for Disease Control and Prevention May PDB ID 4v52 Borovinskaya, M.A. et al. Structural basis for aminoglycoside inhibition of bacterial ribosome recycling. Nat Struct Mol Biol 14, 727-732 (2007) June PDB ID 4wql Cox, G. et al. Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2 )-Ia. MBio 6, mbio.02180-14 (2015)

Visit pdb101.rcsb.org in February 2018 for complete details about the AMRthemed video challenge. If you have any questions, or if you would like to receive a monthly newsletter with news and updates about the challenge, please email info@rcsb.org. ABOUT THIS CALENDAR This calendar was created by RCSB PDB members Luigi Di Costanzo, Sutapa Ghosh, David S. Goodsell, Brian Hudson, Monica Sekharan, Maria Voigt, and Christine Zardecki, and undergraduate researchers Jenna Abyad and Priscilla Salcedo. Molecular images were created using UCSF Chimera [Pettersen, E. F. et al. Chimera a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612 (2004)], Molecular Maya, a plug-in for Autodesk Maya available at clarafi.com, and PyMOL (The PyMOL Molecular Graphics System, Version 1.7.4 Schrödinger, LLC.). July PDB ID 4v1f Preiss, L. et al. Structure of the mycobacterial ATP synthase Fo rotor ring in complex with the anti-tb drug bedaquiline. Sci Adv 1, e1500106 (2015) Lipid bilayer model: Tieleman s Biocomputing Group, University of Calgary August PDB ID 1ll9 Trehan, I. et al. Using steric hindrance to design new inhibitors of class C beta-lactamases. Chem Biol 9, 971-980 (2002) September PDB ID 1e4e Roper, D.I. et al. The molecular basis of vancomycin resistance in clinically relevant Enterococci: crystal structure of D-alanyl-D-lactate ligase (VanA). Proc Natl Acad Sci USA 97, 8921-8925 (2000) October PDB ID 3se7 D Costa, V. M. et al. Antibiotic resistance is ancient. Nature 477, 457-461 (2011) Background Photo: Erosion caused by thawing permafrost. Dentren/CC-BY-3.0 November PDB ID 3q3d Bachas, S. et al. Structural contributions to multidrug recognition in the multidrug resistance (MDR) gene regulator, BmrR. Proc Natl Acad Sci USA 108, 11046-11051 (2011) 1 O Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. Review on Antimicrobial Resistance, London, United Kingdom amr-review.org December PDB ID 5o66 Wang, Z. et al. An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump. Elife 6, elife.24905 (2017)

RCSB.ORG A Living Digital Data Resource that Enables Scientific Breakthroughs Cells rely on many large molecular machines that carry out the complex biological and chemical tasks that sustain life. 3D structures of these machines are freely available at the Protein Data Bank (PDB), the global storehouse of biomolecular structures central to research and education. RCSB.ORG serves >1 million users worldwide each year, providing services that Inform basic and applied research across the sciences Are central to understanding human, animal, and plant health and disease Are critical for drug discovery/development and biotechnology Enable education across biology and medicine PDB101.RCSB.ORG Molecular Explorations through Biology and Medicine PDB-101 is the educational portal of the RCSB PDB developed for teachers, students, and the general public to promote exploration in the 3D world of proteins and nucleic acids. Learning about the diverse shapes and functions of these biological macromolecules helps us to understand all aspects of biomedicine and agriculture, from protein synthesis to health and disease to biological energy. All resources are freely available, including curricular materials, paper molecular models, videos/animations, and more. RCSB PDB is a member of the Worldwide PDB (wwpdb.org). The RCSB PDB is managed by the members of the Research Collaboratory for Structural Bioinformatics: RCSB PDB is funded by a grant (DBI-1338415) from the National Science Foundation, the National Institutes of Health, and the US Department of Energy.